Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.4B | 8.4B | 8.2B | 8.0B |
Cost of revenue | 6.1B | 6.1B | 5.9B | 5.7B |
Gross profit | 2.3B | 2.3B | 2.3B | 2.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 592.9M | 657.7M | 646.1M | 607.4M |
Operating income | 837.0M | 798.8M | 780.5M | 820.9M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 213.8M | 206.6M | 217.4M | 266.0M |
Other income expense | — | — | — | — |
Pretax income | 631.7M | 598.7M | 569.8M | 569.2M |
Tax provision | 168.0M | 150.9M | 148.2M | 148.0M |
Net income | 463.7M | 447.8M | 421.6M | 421.2M |
Basic EPS | — | 8.0 | 7.5 | 7.5 |
Diluted EPS | — | 8.0 | 7.5 | 7.5 |
Basic average shares | — | 56.3M | 56.2M | 56.2M |
Diluted average shares | — | 56.3M | 56.2M | 56.2M |
EBITDA | 1.2B | 1.2B | 1.2B | 1.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |